Amlodipine, Valsartan and Hydrochlorothiazide

Lupin Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Dec 14, 2023
Approval ID: 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe
Products: 5 registered
Version: 11

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS.AMLODIPINE, VALSARTAN and HYDROCHLOROTHIAZIDE tablets, for oral useInitial U.S. Approval: 2009

Quick Stats

Total Products5

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.